{"groups":[{"description":"Tandem autologous hematopoietic stem cell transplantation with melphalan followed by melphalan and bortezomib in patients with multiple myeloma\n\nBortezomib: Bortezomib 1.6mg/m2 on day -4 and day -1","id":"FG000","title":"Tandem Transplantation With Melphalan and Bortezomib"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"6"}],"type":"Withdrawal by Subject"},{"reasons":[{"groupId":"FG000","numSubjects":"6"}],"type":"Screen Failure"},{"reasons":[{"groupId":"FG000","numSubjects":"39"}],"type":"Did not move forward with 2nd Transplant"},{"reasons":[{"groupId":"FG000","numSubjects":"5"}],"type":"Lost to Follow-up"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"148"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"92"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"56"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}